Global Favipiravir API Market Growth 2026-2032
The global Favipiravir API market size is predicted to grow from US$ 1625 million in 2025 to US$ 2223 million in 2032; it is expected to grow at a CAGR of 4.7% from 2026 to 2032.
Favipiravir API is a broad-spectrum antiviral drug with the chemical name 6-fluoro-3-hydroxy-pyrazine-2-carboxamide. It acts on the viral RNA-dependent RNA polymerase, accelerating virus clearance to alleviate viral infections. As an Active Pharmaceutical Ingredient (API) in the pharmaceutical industry, Favipiravir is used to treat diseases caused by various RNA viruses.
United States market for Favipiravir API is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Favipiravir API is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Favipiravir API is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Favipiravir API players cover Chunghwa Chemical Synthesis & Biotech, TODACO, Tagoor Laboratories, Biophore, Lee Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Favipiravir API Industry Forecast? looks at past sales and reviews total world Favipiravir API sales in 2025, providing a comprehensive analysis by region and market sector of projected Favipiravir API sales for 2026 through 2032. With Favipiravir API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Favipiravir API industry.
This Insight Report provides a comprehensive analysis of the global Favipiravir API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Favipiravir API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Favipiravir API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Favipiravir API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Favipiravir API.
This report presents a comprehensive overview, market shares, and growth opportunities of Favipiravir API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Favipiravir API market?
What factors are driving Favipiravir API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Favipiravir API market opportunities vary by end market size?
How does Favipiravir API break out by Type, by Application?
Favipiravir API is a broad-spectrum antiviral drug with the chemical name 6-fluoro-3-hydroxy-pyrazine-2-carboxamide. It acts on the viral RNA-dependent RNA polymerase, accelerating virus clearance to alleviate viral infections. As an Active Pharmaceutical Ingredient (API) in the pharmaceutical industry, Favipiravir is used to treat diseases caused by various RNA viruses.
United States market for Favipiravir API is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Favipiravir API is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Favipiravir API is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Favipiravir API players cover Chunghwa Chemical Synthesis & Biotech, TODACO, Tagoor Laboratories, Biophore, Lee Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Favipiravir API Industry Forecast? looks at past sales and reviews total world Favipiravir API sales in 2025, providing a comprehensive analysis by region and market sector of projected Favipiravir API sales for 2026 through 2032. With Favipiravir API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Favipiravir API industry.
This Insight Report provides a comprehensive analysis of the global Favipiravir API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Favipiravir API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Favipiravir API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Favipiravir API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Favipiravir API.
This report presents a comprehensive overview, market shares, and growth opportunities of Favipiravir API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Purity ? 98%
- Purity < 98%
- Pharmaceuticals
- Scientific Research
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Chunghwa Chemical Synthesis & Biotech
- TODACO
- Tagoor Laboratories
- Biophore
- Lee Pharma
- Forewin Pharma
- Senova Technology
- Zhejiang Hengkang Pharmaceutical
- Maithili Life Sciences
- Hangzhou HETA Pharm & Chem
- Aurore Life Sciences
- Bajaj Healthcare
What is the 10-year outlook for the global Favipiravir API market?
What factors are driving Favipiravir API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Favipiravir API market opportunities vary by end market size?
How does Favipiravir API break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Favipiravir API Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Favipiravir API by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Favipiravir API by Country/Region, 2021, 2025 & 2032
2.2 Favipiravir API Segment by Type
2.2.1 Purity ? 98%
2.2.2 Purity < 98%
2.2.3 Favipiravir API Sales by Type
2.2.3.1 Global Favipiravir API Sales Market Share by Type (2021-2026)
2.2.3.2 Global Favipiravir API Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Favipiravir API Sale Price by Type (2021-2026)
2.3 Favipiravir API Segment by Application
2.3.1 Pharmaceuticals
2.3.2 Scientific Research
2.3.3 Others
2.3.4 Favipiravir API Sales by Application
2.3.4.1 Global Favipiravir API Sale Market Share by Application (2021-2026)
2.3.4.2 Global Favipiravir API Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Favipiravir API Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Favipiravir API Breakdown Data by Company
3.1.1 Global Favipiravir API Annual Sales by Company (2021-2026)
3.1.2 Global Favipiravir API Sales Market Share by Company (2021-2026)
3.2 Global Favipiravir API Annual Revenue by Company (2021-2026)
3.2.1 Global Favipiravir API Revenue by Company (2021-2026)
3.2.2 Global Favipiravir API Revenue Market Share by Company (2021-2026)
3.3 Global Favipiravir API Sale Price by Company
3.4 Key Manufacturers Favipiravir API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Favipiravir API Product Location Distribution
3.4.2 Players Favipiravir API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FAVIPIRAVIR API BY GEOGRAPHIC REGION
4.1 World Historic Favipiravir API Market Size by Geographic Region (2021-2026)
4.1.1 Global Favipiravir API Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Favipiravir API Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Favipiravir API Market Size by Country/Region (2021-2026)
4.2.1 Global Favipiravir API Annual Sales by Country/Region (2021-2026)
4.2.2 Global Favipiravir API Annual Revenue by Country/Region (2021-2026)
4.3 Americas Favipiravir API Sales Growth
4.4 APAC Favipiravir API Sales Growth
4.5 Europe Favipiravir API Sales Growth
4.6 Middle East & Africa Favipiravir API Sales Growth
5 AMERICAS
5.1 Americas Favipiravir API Sales by Country
5.1.1 Americas Favipiravir API Sales by Country (2021-2026)
5.1.2 Americas Favipiravir API Revenue by Country (2021-2026)
5.2 Americas Favipiravir API Sales by Type (2021-2026)
5.3 Americas Favipiravir API Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Favipiravir API Sales by Region
6.1.1 APAC Favipiravir API Sales by Region (2021-2026)
6.1.2 APAC Favipiravir API Revenue by Region (2021-2026)
6.2 APAC Favipiravir API Sales by Type (2021-2026)
6.3 APAC Favipiravir API Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Favipiravir API by Country
7.1.1 Europe Favipiravir API Sales by Country (2021-2026)
7.1.2 Europe Favipiravir API Revenue by Country (2021-2026)
7.2 Europe Favipiravir API Sales by Type (2021-2026)
7.3 Europe Favipiravir API Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Favipiravir API by Country
8.1.1 Middle East & Africa Favipiravir API Sales by Country (2021-2026)
8.1.2 Middle East & Africa Favipiravir API Revenue by Country (2021-2026)
8.2 Middle East & Africa Favipiravir API Sales by Type (2021-2026)
8.3 Middle East & Africa Favipiravir API Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Favipiravir API
10.3 Manufacturing Process Analysis of Favipiravir API
10.4 Industry Chain Structure of Favipiravir API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Favipiravir API Distributors
11.3 Favipiravir API Customer
12 WORLD FORECAST REVIEW FOR FAVIPIRAVIR API BY GEOGRAPHIC REGION
12.1 Global Favipiravir API Market Size Forecast by Region
12.1.1 Global Favipiravir API Forecast by Region (2027-2032)
12.1.2 Global Favipiravir API Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Favipiravir API Forecast by Type (2027-2032)
12.7 Global Favipiravir API Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Chunghwa Chemical Synthesis & Biotech
13.1.1 Chunghwa Chemical Synthesis & Biotech Company Information
13.1.2 Chunghwa Chemical Synthesis & Biotech Favipiravir API Product Portfolios and Specifications
13.1.3 Chunghwa Chemical Synthesis & Biotech Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Chunghwa Chemical Synthesis & Biotech Main Business Overview
13.1.5 Chunghwa Chemical Synthesis & Biotech Latest Developments
13.2 TODACO
13.2.1 TODACO Company Information
13.2.2 TODACO Favipiravir API Product Portfolios and Specifications
13.2.3 TODACO Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 TODACO Main Business Overview
13.2.5 TODACO Latest Developments
13.3 Tagoor Laboratories
13.3.1 Tagoor Laboratories Company Information
13.3.2 Tagoor Laboratories Favipiravir API Product Portfolios and Specifications
13.3.3 Tagoor Laboratories Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Tagoor Laboratories Main Business Overview
13.3.5 Tagoor Laboratories Latest Developments
13.4 Biophore
13.4.1 Biophore Company Information
13.4.2 Biophore Favipiravir API Product Portfolios and Specifications
13.4.3 Biophore Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Biophore Main Business Overview
13.4.5 Biophore Latest Developments
13.5 Lee Pharma
13.5.1 Lee Pharma Company Information
13.5.2 Lee Pharma Favipiravir API Product Portfolios and Specifications
13.5.3 Lee Pharma Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Lee Pharma Main Business Overview
13.5.5 Lee Pharma Latest Developments
13.6 Forewin Pharma
13.6.1 Forewin Pharma Company Information
13.6.2 Forewin Pharma Favipiravir API Product Portfolios and Specifications
13.6.3 Forewin Pharma Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Forewin Pharma Main Business Overview
13.6.5 Forewin Pharma Latest Developments
13.7 Senova Technology
13.7.1 Senova Technology Company Information
13.7.2 Senova Technology Favipiravir API Product Portfolios and Specifications
13.7.3 Senova Technology Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Senova Technology Main Business Overview
13.7.5 Senova Technology Latest Developments
13.8 Zhejiang Hengkang Pharmaceutical
13.8.1 Zhejiang Hengkang Pharmaceutical Company Information
13.8.2 Zhejiang Hengkang Pharmaceutical Favipiravir API Product Portfolios and Specifications
13.8.3 Zhejiang Hengkang Pharmaceutical Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Zhejiang Hengkang Pharmaceutical Main Business Overview
13.8.5 Zhejiang Hengkang Pharmaceutical Latest Developments
13.9 Maithili Life Sciences
13.9.1 Maithili Life Sciences Company Information
13.9.2 Maithili Life Sciences Favipiravir API Product Portfolios and Specifications
13.9.3 Maithili Life Sciences Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Maithili Life Sciences Main Business Overview
13.9.5 Maithili Life Sciences Latest Developments
13.10 Hangzhou HETA Pharm & Chem
13.10.1 Hangzhou HETA Pharm & Chem Company Information
13.10.2 Hangzhou HETA Pharm & Chem Favipiravir API Product Portfolios and Specifications
13.10.3 Hangzhou HETA Pharm & Chem Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Hangzhou HETA Pharm & Chem Main Business Overview
13.10.5 Hangzhou HETA Pharm & Chem Latest Developments
13.11 Aurore Life Sciences
13.11.1 Aurore Life Sciences Company Information
13.11.2 Aurore Life Sciences Favipiravir API Product Portfolios and Specifications
13.11.3 Aurore Life Sciences Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Aurore Life Sciences Main Business Overview
13.11.5 Aurore Life Sciences Latest Developments
13.12 Bajaj Healthcare
13.12.1 Bajaj Healthcare Company Information
13.12.2 Bajaj Healthcare Favipiravir API Product Portfolios and Specifications
13.12.3 Bajaj Healthcare Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Bajaj Healthcare Main Business Overview
13.12.5 Bajaj Healthcare Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Favipiravir API Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Favipiravir API by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Favipiravir API by Country/Region, 2021, 2025 & 2032
2.2 Favipiravir API Segment by Type
2.2.1 Purity ? 98%
2.2.2 Purity < 98%
2.2.3 Favipiravir API Sales by Type
2.2.3.1 Global Favipiravir API Sales Market Share by Type (2021-2026)
2.2.3.2 Global Favipiravir API Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Favipiravir API Sale Price by Type (2021-2026)
2.3 Favipiravir API Segment by Application
2.3.1 Pharmaceuticals
2.3.2 Scientific Research
2.3.3 Others
2.3.4 Favipiravir API Sales by Application
2.3.4.1 Global Favipiravir API Sale Market Share by Application (2021-2026)
2.3.4.2 Global Favipiravir API Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Favipiravir API Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Favipiravir API Breakdown Data by Company
3.1.1 Global Favipiravir API Annual Sales by Company (2021-2026)
3.1.2 Global Favipiravir API Sales Market Share by Company (2021-2026)
3.2 Global Favipiravir API Annual Revenue by Company (2021-2026)
3.2.1 Global Favipiravir API Revenue by Company (2021-2026)
3.2.2 Global Favipiravir API Revenue Market Share by Company (2021-2026)
3.3 Global Favipiravir API Sale Price by Company
3.4 Key Manufacturers Favipiravir API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Favipiravir API Product Location Distribution
3.4.2 Players Favipiravir API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FAVIPIRAVIR API BY GEOGRAPHIC REGION
4.1 World Historic Favipiravir API Market Size by Geographic Region (2021-2026)
4.1.1 Global Favipiravir API Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Favipiravir API Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Favipiravir API Market Size by Country/Region (2021-2026)
4.2.1 Global Favipiravir API Annual Sales by Country/Region (2021-2026)
4.2.2 Global Favipiravir API Annual Revenue by Country/Region (2021-2026)
4.3 Americas Favipiravir API Sales Growth
4.4 APAC Favipiravir API Sales Growth
4.5 Europe Favipiravir API Sales Growth
4.6 Middle East & Africa Favipiravir API Sales Growth
5 AMERICAS
5.1 Americas Favipiravir API Sales by Country
5.1.1 Americas Favipiravir API Sales by Country (2021-2026)
5.1.2 Americas Favipiravir API Revenue by Country (2021-2026)
5.2 Americas Favipiravir API Sales by Type (2021-2026)
5.3 Americas Favipiravir API Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Favipiravir API Sales by Region
6.1.1 APAC Favipiravir API Sales by Region (2021-2026)
6.1.2 APAC Favipiravir API Revenue by Region (2021-2026)
6.2 APAC Favipiravir API Sales by Type (2021-2026)
6.3 APAC Favipiravir API Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Favipiravir API by Country
7.1.1 Europe Favipiravir API Sales by Country (2021-2026)
7.1.2 Europe Favipiravir API Revenue by Country (2021-2026)
7.2 Europe Favipiravir API Sales by Type (2021-2026)
7.3 Europe Favipiravir API Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Favipiravir API by Country
8.1.1 Middle East & Africa Favipiravir API Sales by Country (2021-2026)
8.1.2 Middle East & Africa Favipiravir API Revenue by Country (2021-2026)
8.2 Middle East & Africa Favipiravir API Sales by Type (2021-2026)
8.3 Middle East & Africa Favipiravir API Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Favipiravir API
10.3 Manufacturing Process Analysis of Favipiravir API
10.4 Industry Chain Structure of Favipiravir API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Favipiravir API Distributors
11.3 Favipiravir API Customer
12 WORLD FORECAST REVIEW FOR FAVIPIRAVIR API BY GEOGRAPHIC REGION
12.1 Global Favipiravir API Market Size Forecast by Region
12.1.1 Global Favipiravir API Forecast by Region (2027-2032)
12.1.2 Global Favipiravir API Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Favipiravir API Forecast by Type (2027-2032)
12.7 Global Favipiravir API Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Chunghwa Chemical Synthesis & Biotech
13.1.1 Chunghwa Chemical Synthesis & Biotech Company Information
13.1.2 Chunghwa Chemical Synthesis & Biotech Favipiravir API Product Portfolios and Specifications
13.1.3 Chunghwa Chemical Synthesis & Biotech Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Chunghwa Chemical Synthesis & Biotech Main Business Overview
13.1.5 Chunghwa Chemical Synthesis & Biotech Latest Developments
13.2 TODACO
13.2.1 TODACO Company Information
13.2.2 TODACO Favipiravir API Product Portfolios and Specifications
13.2.3 TODACO Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 TODACO Main Business Overview
13.2.5 TODACO Latest Developments
13.3 Tagoor Laboratories
13.3.1 Tagoor Laboratories Company Information
13.3.2 Tagoor Laboratories Favipiravir API Product Portfolios and Specifications
13.3.3 Tagoor Laboratories Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Tagoor Laboratories Main Business Overview
13.3.5 Tagoor Laboratories Latest Developments
13.4 Biophore
13.4.1 Biophore Company Information
13.4.2 Biophore Favipiravir API Product Portfolios and Specifications
13.4.3 Biophore Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Biophore Main Business Overview
13.4.5 Biophore Latest Developments
13.5 Lee Pharma
13.5.1 Lee Pharma Company Information
13.5.2 Lee Pharma Favipiravir API Product Portfolios and Specifications
13.5.3 Lee Pharma Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Lee Pharma Main Business Overview
13.5.5 Lee Pharma Latest Developments
13.6 Forewin Pharma
13.6.1 Forewin Pharma Company Information
13.6.2 Forewin Pharma Favipiravir API Product Portfolios and Specifications
13.6.3 Forewin Pharma Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Forewin Pharma Main Business Overview
13.6.5 Forewin Pharma Latest Developments
13.7 Senova Technology
13.7.1 Senova Technology Company Information
13.7.2 Senova Technology Favipiravir API Product Portfolios and Specifications
13.7.3 Senova Technology Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Senova Technology Main Business Overview
13.7.5 Senova Technology Latest Developments
13.8 Zhejiang Hengkang Pharmaceutical
13.8.1 Zhejiang Hengkang Pharmaceutical Company Information
13.8.2 Zhejiang Hengkang Pharmaceutical Favipiravir API Product Portfolios and Specifications
13.8.3 Zhejiang Hengkang Pharmaceutical Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Zhejiang Hengkang Pharmaceutical Main Business Overview
13.8.5 Zhejiang Hengkang Pharmaceutical Latest Developments
13.9 Maithili Life Sciences
13.9.1 Maithili Life Sciences Company Information
13.9.2 Maithili Life Sciences Favipiravir API Product Portfolios and Specifications
13.9.3 Maithili Life Sciences Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Maithili Life Sciences Main Business Overview
13.9.5 Maithili Life Sciences Latest Developments
13.10 Hangzhou HETA Pharm & Chem
13.10.1 Hangzhou HETA Pharm & Chem Company Information
13.10.2 Hangzhou HETA Pharm & Chem Favipiravir API Product Portfolios and Specifications
13.10.3 Hangzhou HETA Pharm & Chem Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Hangzhou HETA Pharm & Chem Main Business Overview
13.10.5 Hangzhou HETA Pharm & Chem Latest Developments
13.11 Aurore Life Sciences
13.11.1 Aurore Life Sciences Company Information
13.11.2 Aurore Life Sciences Favipiravir API Product Portfolios and Specifications
13.11.3 Aurore Life Sciences Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Aurore Life Sciences Main Business Overview
13.11.5 Aurore Life Sciences Latest Developments
13.12 Bajaj Healthcare
13.12.1 Bajaj Healthcare Company Information
13.12.2 Bajaj Healthcare Favipiravir API Product Portfolios and Specifications
13.12.3 Bajaj Healthcare Favipiravir API Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Bajaj Healthcare Main Business Overview
13.12.5 Bajaj Healthcare Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Favipiravir API Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Favipiravir API Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Purity ? 98%
Table 4. Major Players of Purity < 98%
Table 5. Global Favipiravir API Sales by Type (2021-2026) & (Tons)
Table 6. Global Favipiravir API Sales Market Share by Type (2021-2026)
Table 7. Global Favipiravir API Revenue by Type (2021-2026) & ($ million)
Table 8. Global Favipiravir API Revenue Market Share by Type (2021-2026)
Table 9. Global Favipiravir API Sale Price by Type (2021-2026) & (US$/Ton)
Table 10. Global Favipiravir API Sale by Application (2021-2026) & (Tons)
Table 11. Global Favipiravir API Sale Market Share by Application (2021-2026)
Table 12. Global Favipiravir API Revenue by Application (2021-2026) & ($ million)
Table 13. Global Favipiravir API Revenue Market Share by Application (2021-2026)
Table 14. Global Favipiravir API Sale Price by Application (2021-2026) & (US$/Ton)
Table 15. Global Favipiravir API Sales by Company (2021-2026) & (Tons)
Table 16. Global Favipiravir API Sales Market Share by Company (2021-2026)
Table 17. Global Favipiravir API Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Favipiravir API Revenue Market Share by Company (2021-2026)
Table 19. Global Favipiravir API Sale Price by Company (2021-2026) & (US$/Ton)
Table 20. Key Manufacturers Favipiravir API Producing Area Distribution and Sales Area
Table 21. Players Favipiravir API Products Offered
Table 22. Favipiravir API Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Favipiravir API Sales by Geographic Region (2021-2026) & (Tons)
Table 26. Global Favipiravir API Sales Market Share Geographic Region (2021-2026)
Table 27. Global Favipiravir API Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Favipiravir API Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Favipiravir API Sales by Country/Region (2021-2026) & (Tons)
Table 30. Global Favipiravir API Sales Market Share by Country/Region (2021-2026)
Table 31. Global Favipiravir API Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Favipiravir API Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Favipiravir API Sales by Country (2021-2026) & (Tons)
Table 34. Americas Favipiravir API Sales Market Share by Country (2021-2026)
Table 35. Americas Favipiravir API Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Favipiravir API Sales by Type (2021-2026) & (Tons)
Table 37. Americas Favipiravir API Sales by Application (2021-2026) & (Tons)
Table 38. APAC Favipiravir API Sales by Region (2021-2026) & (Tons)
Table 39. APAC Favipiravir API Sales Market Share by Region (2021-2026)
Table 40. APAC Favipiravir API Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Favipiravir API Sales by Type (2021-2026) & (Tons)
Table 42. APAC Favipiravir API Sales by Application (2021-2026) & (Tons)
Table 43. Europe Favipiravir API Sales by Country (2021-2026) & (Tons)
Table 44. Europe Favipiravir API Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Favipiravir API Sales by Type (2021-2026) & (Tons)
Table 46. Europe Favipiravir API Sales by Application (2021-2026) & (Tons)
Table 47. Middle East & Africa Favipiravir API Sales by Country (2021-2026) & (Tons)
Table 48. Middle East & Africa Favipiravir API Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Favipiravir API Sales by Type (2021-2026) & (Tons)
Table 50. Middle East & Africa Favipiravir API Sales by Application (2021-2026) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Favipiravir API
Table 52. Key Market Challenges & Risks of Favipiravir API
Table 53. Key Industry Trends of Favipiravir API
Table 54. Favipiravir API Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Favipiravir API Distributors List
Table 57. Favipiravir API Customer List
Table 58. Global Favipiravir API Sales Forecast by Region (2027-2032) & (Tons)
Table 59. Global Favipiravir API Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Favipiravir API Sales Forecast by Country (2027-2032) & (Tons)
Table 61. Americas Favipiravir API Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Favipiravir API Sales Forecast by Region (2027-2032) & (Tons)
Table 63. APAC Favipiravir API Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Favipiravir API Sales Forecast by Country (2027-2032) & (Tons)
Table 65. Europe Favipiravir API Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Favipiravir API Sales Forecast by Country (2027-2032) & (Tons)
Table 67. Middle East & Africa Favipiravir API Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Favipiravir API Sales Forecast by Type (2027-2032) & (Tons)
Table 69. Global Favipiravir API Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Favipiravir API Sales Forecast by Application (2027-2032) & (Tons)
Table 71. Global Favipiravir API Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Chunghwa Chemical Synthesis & Biotech Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 73. Chunghwa Chemical Synthesis & Biotech Favipiravir API Product Portfolios and Specifications
Table 74. Chunghwa Chemical Synthesis & Biotech Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 75. Chunghwa Chemical Synthesis & Biotech Main Business
Table 76. Chunghwa Chemical Synthesis & Biotech Latest Developments
Table 77. TODACO Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 78. TODACO Favipiravir API Product Portfolios and Specifications
Table 79. TODACO Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 80. TODACO Main Business
Table 81. TODACO Latest Developments
Table 82. Tagoor Laboratories Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 83. Tagoor Laboratories Favipiravir API Product Portfolios and Specifications
Table 84. Tagoor Laboratories Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 85. Tagoor Laboratories Main Business
Table 86. Tagoor Laboratories Latest Developments
Table 87. Biophore Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 88. Biophore Favipiravir API Product Portfolios and Specifications
Table 89. Biophore Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 90. Biophore Main Business
Table 91. Biophore Latest Developments
Table 92. Lee Pharma Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 93. Lee Pharma Favipiravir API Product Portfolios and Specifications
Table 94. Lee Pharma Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 95. Lee Pharma Main Business
Table 96. Lee Pharma Latest Developments
Table 97. Forewin Pharma Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 98. Forewin Pharma Favipiravir API Product Portfolios and Specifications
Table 99. Forewin Pharma Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 100. Forewin Pharma Main Business
Table 101. Forewin Pharma Latest Developments
Table 102. Senova Technology Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 103. Senova Technology Favipiravir API Product Portfolios and Specifications
Table 104. Senova Technology Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 105. Senova Technology Main Business
Table 106. Senova Technology Latest Developments
Table 107. Zhejiang Hengkang Pharmaceutical Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 108. Zhejiang Hengkang Pharmaceutical Favipiravir API Product Portfolios and Specifications
Table 109. Zhejiang Hengkang Pharmaceutical Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 110. Zhejiang Hengkang Pharmaceutical Main Business
Table 111. Zhejiang Hengkang Pharmaceutical Latest Developments
Table 112. Maithili Life Sciences Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 113. Maithili Life Sciences Favipiravir API Product Portfolios and Specifications
Table 114. Maithili Life Sciences Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 115. Maithili Life Sciences Main Business
Table 116. Maithili Life Sciences Latest Developments
Table 117. Hangzhou HETA Pharm & Chem Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 118. Hangzhou HETA Pharm & Chem Favipiravir API Product Portfolios and Specifications
Table 119. Hangzhou HETA Pharm & Chem Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 120. Hangzhou HETA Pharm & Chem Main Business
Table 121. Hangzhou HETA Pharm & Chem Latest Developments
Table 122. Aurore Life Sciences Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 123. Aurore Life Sciences Favipiravir API Product Portfolios and Specifications
Table 124. Aurore Life Sciences Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 125. Aurore Life Sciences Main Business
Table 126. Aurore Life Sciences Latest Developments
Table 127. Bajaj Healthcare Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 128. Bajaj Healthcare Favipiravir API Product Portfolios and Specifications
Table 129. Bajaj Healthcare Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 130. Bajaj Healthcare Main Business
Table 131. Bajaj Healthcare Latest Developments
Table 1. Favipiravir API Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Favipiravir API Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Purity ? 98%
Table 4. Major Players of Purity < 98%
Table 5. Global Favipiravir API Sales by Type (2021-2026) & (Tons)
Table 6. Global Favipiravir API Sales Market Share by Type (2021-2026)
Table 7. Global Favipiravir API Revenue by Type (2021-2026) & ($ million)
Table 8. Global Favipiravir API Revenue Market Share by Type (2021-2026)
Table 9. Global Favipiravir API Sale Price by Type (2021-2026) & (US$/Ton)
Table 10. Global Favipiravir API Sale by Application (2021-2026) & (Tons)
Table 11. Global Favipiravir API Sale Market Share by Application (2021-2026)
Table 12. Global Favipiravir API Revenue by Application (2021-2026) & ($ million)
Table 13. Global Favipiravir API Revenue Market Share by Application (2021-2026)
Table 14. Global Favipiravir API Sale Price by Application (2021-2026) & (US$/Ton)
Table 15. Global Favipiravir API Sales by Company (2021-2026) & (Tons)
Table 16. Global Favipiravir API Sales Market Share by Company (2021-2026)
Table 17. Global Favipiravir API Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Favipiravir API Revenue Market Share by Company (2021-2026)
Table 19. Global Favipiravir API Sale Price by Company (2021-2026) & (US$/Ton)
Table 20. Key Manufacturers Favipiravir API Producing Area Distribution and Sales Area
Table 21. Players Favipiravir API Products Offered
Table 22. Favipiravir API Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Favipiravir API Sales by Geographic Region (2021-2026) & (Tons)
Table 26. Global Favipiravir API Sales Market Share Geographic Region (2021-2026)
Table 27. Global Favipiravir API Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Favipiravir API Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Favipiravir API Sales by Country/Region (2021-2026) & (Tons)
Table 30. Global Favipiravir API Sales Market Share by Country/Region (2021-2026)
Table 31. Global Favipiravir API Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Favipiravir API Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Favipiravir API Sales by Country (2021-2026) & (Tons)
Table 34. Americas Favipiravir API Sales Market Share by Country (2021-2026)
Table 35. Americas Favipiravir API Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Favipiravir API Sales by Type (2021-2026) & (Tons)
Table 37. Americas Favipiravir API Sales by Application (2021-2026) & (Tons)
Table 38. APAC Favipiravir API Sales by Region (2021-2026) & (Tons)
Table 39. APAC Favipiravir API Sales Market Share by Region (2021-2026)
Table 40. APAC Favipiravir API Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Favipiravir API Sales by Type (2021-2026) & (Tons)
Table 42. APAC Favipiravir API Sales by Application (2021-2026) & (Tons)
Table 43. Europe Favipiravir API Sales by Country (2021-2026) & (Tons)
Table 44. Europe Favipiravir API Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Favipiravir API Sales by Type (2021-2026) & (Tons)
Table 46. Europe Favipiravir API Sales by Application (2021-2026) & (Tons)
Table 47. Middle East & Africa Favipiravir API Sales by Country (2021-2026) & (Tons)
Table 48. Middle East & Africa Favipiravir API Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Favipiravir API Sales by Type (2021-2026) & (Tons)
Table 50. Middle East & Africa Favipiravir API Sales by Application (2021-2026) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Favipiravir API
Table 52. Key Market Challenges & Risks of Favipiravir API
Table 53. Key Industry Trends of Favipiravir API
Table 54. Favipiravir API Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Favipiravir API Distributors List
Table 57. Favipiravir API Customer List
Table 58. Global Favipiravir API Sales Forecast by Region (2027-2032) & (Tons)
Table 59. Global Favipiravir API Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Favipiravir API Sales Forecast by Country (2027-2032) & (Tons)
Table 61. Americas Favipiravir API Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Favipiravir API Sales Forecast by Region (2027-2032) & (Tons)
Table 63. APAC Favipiravir API Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Favipiravir API Sales Forecast by Country (2027-2032) & (Tons)
Table 65. Europe Favipiravir API Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Favipiravir API Sales Forecast by Country (2027-2032) & (Tons)
Table 67. Middle East & Africa Favipiravir API Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Favipiravir API Sales Forecast by Type (2027-2032) & (Tons)
Table 69. Global Favipiravir API Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Favipiravir API Sales Forecast by Application (2027-2032) & (Tons)
Table 71. Global Favipiravir API Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Chunghwa Chemical Synthesis & Biotech Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 73. Chunghwa Chemical Synthesis & Biotech Favipiravir API Product Portfolios and Specifications
Table 74. Chunghwa Chemical Synthesis & Biotech Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 75. Chunghwa Chemical Synthesis & Biotech Main Business
Table 76. Chunghwa Chemical Synthesis & Biotech Latest Developments
Table 77. TODACO Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 78. TODACO Favipiravir API Product Portfolios and Specifications
Table 79. TODACO Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 80. TODACO Main Business
Table 81. TODACO Latest Developments
Table 82. Tagoor Laboratories Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 83. Tagoor Laboratories Favipiravir API Product Portfolios and Specifications
Table 84. Tagoor Laboratories Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 85. Tagoor Laboratories Main Business
Table 86. Tagoor Laboratories Latest Developments
Table 87. Biophore Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 88. Biophore Favipiravir API Product Portfolios and Specifications
Table 89. Biophore Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 90. Biophore Main Business
Table 91. Biophore Latest Developments
Table 92. Lee Pharma Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 93. Lee Pharma Favipiravir API Product Portfolios and Specifications
Table 94. Lee Pharma Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 95. Lee Pharma Main Business
Table 96. Lee Pharma Latest Developments
Table 97. Forewin Pharma Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 98. Forewin Pharma Favipiravir API Product Portfolios and Specifications
Table 99. Forewin Pharma Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 100. Forewin Pharma Main Business
Table 101. Forewin Pharma Latest Developments
Table 102. Senova Technology Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 103. Senova Technology Favipiravir API Product Portfolios and Specifications
Table 104. Senova Technology Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 105. Senova Technology Main Business
Table 106. Senova Technology Latest Developments
Table 107. Zhejiang Hengkang Pharmaceutical Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 108. Zhejiang Hengkang Pharmaceutical Favipiravir API Product Portfolios and Specifications
Table 109. Zhejiang Hengkang Pharmaceutical Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 110. Zhejiang Hengkang Pharmaceutical Main Business
Table 111. Zhejiang Hengkang Pharmaceutical Latest Developments
Table 112. Maithili Life Sciences Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 113. Maithili Life Sciences Favipiravir API Product Portfolios and Specifications
Table 114. Maithili Life Sciences Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 115. Maithili Life Sciences Main Business
Table 116. Maithili Life Sciences Latest Developments
Table 117. Hangzhou HETA Pharm & Chem Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 118. Hangzhou HETA Pharm & Chem Favipiravir API Product Portfolios and Specifications
Table 119. Hangzhou HETA Pharm & Chem Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 120. Hangzhou HETA Pharm & Chem Main Business
Table 121. Hangzhou HETA Pharm & Chem Latest Developments
Table 122. Aurore Life Sciences Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 123. Aurore Life Sciences Favipiravir API Product Portfolios and Specifications
Table 124. Aurore Life Sciences Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 125. Aurore Life Sciences Main Business
Table 126. Aurore Life Sciences Latest Developments
Table 127. Bajaj Healthcare Basic Information, Favipiravir API Manufacturing Base, Sales Area and Its Competitors
Table 128. Bajaj Healthcare Favipiravir API Product Portfolios and Specifications
Table 129. Bajaj Healthcare Favipiravir API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 130. Bajaj Healthcare Main Business
Table 131. Bajaj Healthcare Latest Developments
LIST OF FIGURES
Figure 1. Picture of Favipiravir API
Figure 2. Favipiravir API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Favipiravir API Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Favipiravir API Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Favipiravir API Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Favipiravir API Sales Market Share by Country/Region (2025)
Figure 10. Favipiravir API Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Purity ? 98%
Figure 12. Product Picture of Purity < 98%
Figure 13. Global Favipiravir API Sales Market Share by Type in 2026
Figure 14. Global Favipiravir API Revenue Market Share by Type (2021-2026)
Figure 15. Favipiravir API Consumed in Pharmaceuticals
Figure 16. Global Favipiravir API Market: Pharmaceuticals (2021-2026) & (Tons)
Figure 17. Favipiravir API Consumed in Scientific Research
Figure 18. Global Favipiravir API Market: Scientific Research (2021-2026) & (Tons)
Figure 19. Favipiravir API Consumed in Others
Figure 20. Global Favipiravir API Market: Others (2021-2026) & (Tons)
Figure 21. Global Favipiravir API Sale Market Share by Application (2025)
Figure 22. Global Favipiravir API Revenue Market Share by Application in 2026
Figure 23. Favipiravir API Sales by Company in 2026 (Tons)
Figure 24. Global Favipiravir API Sales Market Share by Company in 2026
Figure 25. Favipiravir API Revenue by Company in 2026 ($ millions)
Figure 26. Global Favipiravir API Revenue Market Share by Company in 2026
Figure 27. Global Favipiravir API Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Favipiravir API Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Favipiravir API Sales 2021-2026 (Tons)
Figure 30. Americas Favipiravir API Revenue 2021-2026 ($ millions)
Figure 31. APAC Favipiravir API Sales 2021-2026 (Tons)
Figure 32. APAC Favipiravir API Revenue 2021-2026 ($ millions)
Figure 33. Europe Favipiravir API Sales 2021-2026 (Tons)
Figure 34. Europe Favipiravir API Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Favipiravir API Sales 2021-2026 (Tons)
Figure 36. Middle East & Africa Favipiravir API Revenue 2021-2026 ($ millions)
Figure 37. Americas Favipiravir API Sales Market Share by Country in 2026
Figure 38. Americas Favipiravir API Revenue Market Share by Country (2021-2026)
Figure 39. Americas Favipiravir API Sales Market Share by Type (2021-2026)
Figure 40. Americas Favipiravir API Sales Market Share by Application (2021-2026)
Figure 41. United States Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Favipiravir API Sales Market Share by Region in 2026
Figure 46. APAC Favipiravir API Revenue Market Share by Region (2021-2026)
Figure 47. APAC Favipiravir API Sales Market Share by Type (2021-2026)
Figure 48. APAC Favipiravir API Sales Market Share by Application (2021-2026)
Figure 49. China Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 53. India Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Favipiravir API Sales Market Share by Country in 2026
Figure 57. Europe Favipiravir API Revenue Market Share by Country (2021-2026)
Figure 58. Europe Favipiravir API Sales Market Share by Type (2021-2026)
Figure 59. Europe Favipiravir API Sales Market Share by Application (2021-2026)
Figure 60. Germany Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 61. France Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Favipiravir API Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Favipiravir API Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Favipiravir API Sales Market Share by Application (2021-2026)
Figure 68. Egypt Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Favipiravir API in 2026
Figure 74. Manufacturing Process Analysis of Favipiravir API
Figure 75. Industry Chain Structure of Favipiravir API
Figure 76. Channels of Distribution
Figure 77. Global Favipiravir API Sales Market Forecast by Region (2027-2032)
Figure 78. Global Favipiravir API Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Favipiravir API Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Favipiravir API Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Favipiravir API Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Favipiravir API Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Favipiravir API
Figure 2. Favipiravir API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Favipiravir API Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Favipiravir API Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Favipiravir API Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Favipiravir API Sales Market Share by Country/Region (2025)
Figure 10. Favipiravir API Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Purity ? 98%
Figure 12. Product Picture of Purity < 98%
Figure 13. Global Favipiravir API Sales Market Share by Type in 2026
Figure 14. Global Favipiravir API Revenue Market Share by Type (2021-2026)
Figure 15. Favipiravir API Consumed in Pharmaceuticals
Figure 16. Global Favipiravir API Market: Pharmaceuticals (2021-2026) & (Tons)
Figure 17. Favipiravir API Consumed in Scientific Research
Figure 18. Global Favipiravir API Market: Scientific Research (2021-2026) & (Tons)
Figure 19. Favipiravir API Consumed in Others
Figure 20. Global Favipiravir API Market: Others (2021-2026) & (Tons)
Figure 21. Global Favipiravir API Sale Market Share by Application (2025)
Figure 22. Global Favipiravir API Revenue Market Share by Application in 2026
Figure 23. Favipiravir API Sales by Company in 2026 (Tons)
Figure 24. Global Favipiravir API Sales Market Share by Company in 2026
Figure 25. Favipiravir API Revenue by Company in 2026 ($ millions)
Figure 26. Global Favipiravir API Revenue Market Share by Company in 2026
Figure 27. Global Favipiravir API Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Favipiravir API Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Favipiravir API Sales 2021-2026 (Tons)
Figure 30. Americas Favipiravir API Revenue 2021-2026 ($ millions)
Figure 31. APAC Favipiravir API Sales 2021-2026 (Tons)
Figure 32. APAC Favipiravir API Revenue 2021-2026 ($ millions)
Figure 33. Europe Favipiravir API Sales 2021-2026 (Tons)
Figure 34. Europe Favipiravir API Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Favipiravir API Sales 2021-2026 (Tons)
Figure 36. Middle East & Africa Favipiravir API Revenue 2021-2026 ($ millions)
Figure 37. Americas Favipiravir API Sales Market Share by Country in 2026
Figure 38. Americas Favipiravir API Revenue Market Share by Country (2021-2026)
Figure 39. Americas Favipiravir API Sales Market Share by Type (2021-2026)
Figure 40. Americas Favipiravir API Sales Market Share by Application (2021-2026)
Figure 41. United States Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Favipiravir API Sales Market Share by Region in 2026
Figure 46. APAC Favipiravir API Revenue Market Share by Region (2021-2026)
Figure 47. APAC Favipiravir API Sales Market Share by Type (2021-2026)
Figure 48. APAC Favipiravir API Sales Market Share by Application (2021-2026)
Figure 49. China Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 53. India Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Favipiravir API Sales Market Share by Country in 2026
Figure 57. Europe Favipiravir API Revenue Market Share by Country (2021-2026)
Figure 58. Europe Favipiravir API Sales Market Share by Type (2021-2026)
Figure 59. Europe Favipiravir API Sales Market Share by Application (2021-2026)
Figure 60. Germany Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 61. France Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Favipiravir API Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Favipiravir API Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Favipiravir API Sales Market Share by Application (2021-2026)
Figure 68. Egypt Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Favipiravir API Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Favipiravir API in 2026
Figure 74. Manufacturing Process Analysis of Favipiravir API
Figure 75. Industry Chain Structure of Favipiravir API
Figure 76. Channels of Distribution
Figure 77. Global Favipiravir API Sales Market Forecast by Region (2027-2032)
Figure 78. Global Favipiravir API Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Favipiravir API Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Favipiravir API Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Favipiravir API Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Favipiravir API Revenue Market Share Forecast by Application (2027-2032)
